| Title |
Omega-3 fatty acids for treatment of non-alcoholic fatty liver disease: design and rationale of randomized controlled trial
|
|---|---|
| Published in |
BMC Pediatrics, May 2013
|
| DOI | 10.1186/1471-2431-13-85 |
| Pubmed ID | |
| Authors |
Wojciech Janczyk, Piotr Socha, Dariusz Lebensztejn, Aldona Wierzbicka, Artur Mazur, Joanna Neuhoff-Murawska, Pawel Matusik |
| Abstract |
Non-alcoholic fatty liver disease (NAFLD) is a liver manifestation of metabolic syndrome since obesity and insulin resistance are the main pathogenic contributors for both conditions. NAFLD carries increased risk of atherosclerosis and cardiovascular diseases. There is an urgent need to find effective and safe therapy for children and adults with NAFLD. Data from research and clinical studies suggest that omega-3 fatty acids may be beneficial in metabolic syndrome-related conditions and can reduce the risk of cardiovascular disease. |
X Demographics
The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 6 | 60% |
| Canada | 1 | 10% |
| Unknown | 3 | 30% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 9 | 90% |
| Practitioners (doctors, other healthcare professionals) | 1 | 10% |
Mendeley readers
The data shown below were compiled from readership statistics for 235 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Indonesia | 1 | <1% |
| United Kingdom | 1 | <1% |
| India | 1 | <1% |
| Unknown | 232 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 42 | 18% |
| Student > Master | 35 | 15% |
| Researcher | 29 | 12% |
| Student > Ph. D. Student | 21 | 9% |
| Student > Postgraduate | 16 | 7% |
| Other | 34 | 14% |
| Unknown | 58 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 72 | 31% |
| Nursing and Health Professions | 25 | 11% |
| Agricultural and Biological Sciences | 21 | 9% |
| Sports and Recreations | 11 | 5% |
| Biochemistry, Genetics and Molecular Biology | 10 | 4% |
| Other | 26 | 11% |
| Unknown | 70 | 30% |
Attention Score in Context
This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 September 2023.
All research outputs
#4,356,423
of 24,374,350 outputs
Outputs from BMC Pediatrics
#722
of 3,261 outputs
Outputs of similar age
#35,549
of 198,963 outputs
Outputs of similar age from BMC Pediatrics
#10
of 43 outputs
Altmetric has tracked 24,374,350 research outputs across all sources so far. Compared to these this one has done well and is in the 82nd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,261 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.9. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 198,963 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 43 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 79% of its contemporaries.